Agilent Technologies Inc vs ServiceNow Inc — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while ServiceNow Inc trades at $127.09 (market cap $129.11B). The key difference: ServiceNow Inc is far larger — about 3.1× Agilent Technologies Inc's market cap, and Agilent Technologies Inc pays a 0.69% dividend while ServiceNow Inc pays none. Which is the better fit depends on your goals.
| A | NOW | |
|---|---|---|
Market Cap | $42.00B | $129.11B |
Sector | Health | Technology |
52-Week High | $157.20 | $192.23 |
52-Week Low | $110.24 | $83.00 |
Enterprise Value | $43.55B | $132.90B |
Dividend Yield | 0.69% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
ServiceNow (NOW) trades at $124.88, up 6.42% in the last 24 hours, reflecting strong momentum near its pivot point of $124. The stock shows bullish technical signals with moving averages supporting an uptrend, though RSI levels indicate potential overbought conditions. Fundamentally, revenue grew to $13.28 billion in 2025 with a net income margin of 11.34%, but high valuation ratios like a P/E of 78.05 suggest premium pricing. Recent news highlights AI-driven growth opportunities and conference presentations boosting investor confidence.
The outlook for NOW is positive with an analyst consensus price target of $138.26, implying ~11% upside. Key opportunities include AI integration and revenue expansion, but risks involve elevated valuations and competitive pressures. Earnings consistency remains crucial, with Q3 2026 results anticipated to validate growth trajectory.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management (ITSM), expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service (PaaS).
Read more on NOW →